424B3

Prospectus

Avalo Therapeutics, Inc. Filed 2017-03-02 Acc 0001628280-17-002113

Documents 1

424B3 Prospectus , cerc424b320170302.htm

Around this filing

Link to a passage

External

SEC EDGAR (opens in new tab)